146 related articles for article (PubMed ID: 8946632)
1. Status of local cellular immunity in interferon-responsive and -nonresponsive human papillomavirus-associated lesions.
Arany I; Tyring SK
Sex Transm Dis; 1996; 23(6):475-80. PubMed ID: 8946632
[TBL] [Abstract][Full Text] [Related]
2. Tissue specific HPV expression and downregulation of local immune responses in condylomas from HIV seropositive individuals.
Arany I; Evans T; Tyring SK
Sex Transm Infect; 1998 Oct; 74(5):349-53. PubMed ID: 10195031
[TBL] [Abstract][Full Text] [Related]
3. Systemic immunosuppression by HIV infection influences HPV transcription and thus local immune responses in condyloma acuminatum.
Arany I; Tyring SK
Int J STD AIDS; 1998 May; 9(5):268-71. PubMed ID: 9639204
[TBL] [Abstract][Full Text] [Related]
4. Activation of local cell-mediated immunity in interferon-responsive patients with human papillomavirus-associated lesions.
Arany I; Tyring SK
J Interferon Cytokine Res; 1996 Jun; 16(6):453-60. PubMed ID: 8807499
[TBL] [Abstract][Full Text] [Related]
5. Interferon response depends on viral transcription in human papillomavirus-containing lesions.
Arany I; Goel A; Tyring SK
Anticancer Res; 1995; 15(6B):2865-9. PubMed ID: 8669880
[TBL] [Abstract][Full Text] [Related]
6. Spontaneous or interferon-gamma-induced T-cell infiltration, HLA-DR and ICAM-1 expression in genitoanal warts are associated with TH1 or mixed TH1/TH2 cytokine mRNA expression profiles.
Grassegger A; Rollinger-Holzinger I; Zelger BW; Heim K; Zwierzina H; Fritsch PO; Höpfl RM
Arch Dermatol Res; 1997 Apr; 289(5):243-50. PubMed ID: 9164632
[TBL] [Abstract][Full Text] [Related]
7. Interferon resistance is independent from copy numbers in benign HPV-induced lesions.
Arany I; Nagamani K; Tyring SK
Anticancer Res; 1995; 15(3):1003-6. PubMed ID: 7645918
[TBL] [Abstract][Full Text] [Related]
8. Photodynamic Therapy for Genital Warts Causes Activation of Local Immunity.
Xie F; Yu HS; Wang R; Wang D; Li YM; Wen HY; Du JB; Ba W; Meng XF; Yang J; Lin BW; Li HJ; Li CX; Zhang LG; Fang XD; Zhao H
J Cutan Med Surg; 2019; 23(4):370-379. PubMed ID: 31010295
[TBL] [Abstract][Full Text] [Related]
9. Immunological events in regressing genital warts.
Coleman N; Birley HD; Renton AM; Hanna NF; Ryait BK; Byrne M; Taylor-Robinson D; Stanley MA
Am J Clin Pathol; 1994 Dec; 102(6):768-74. PubMed ID: 7801889
[TBL] [Abstract][Full Text] [Related]
10. Relation of p53 tumor suppressor protein expression to human papillomavirus (HPV) DNA and to cellular atypia in male genital warts and in premalignant lesions.
Ranki A; Lassus J; Niemi KM
Acta Derm Venereol; 1995 May; 75(3):180-6. PubMed ID: 7653176
[TBL] [Abstract][Full Text] [Related]
11. [Mechanisms of imiquimod indirect antiviral activity].
Hober D; Ajram L; Chehadeh W; Lazrek M; Goffard A; Dewilde A; Wattré P
Ann Biol Clin (Paris); 2005; 63(2):155-63. PubMed ID: 15771973
[TBL] [Abstract][Full Text] [Related]
12. Genital warts.
Dupin N
Clin Dermatol; 2004; 22(6):481-6. PubMed ID: 15596319
[TBL] [Abstract][Full Text] [Related]
13. Langerhans cells, inflammation markers and human papillomavirus infections in benign and malignant epithelial tumors from transplant recipients.
Viac J; Chardonnet Y; Euvrard S; Chignol MC; Thivolet J
J Dermatol; 1992 Feb; 19(2):67-77. PubMed ID: 1352312
[TBL] [Abstract][Full Text] [Related]
14. Interferon treatment enhances the expression of underphosphorylated (biologically-active) retinoblastoma protein in human papilloma virus-infected cells through the inhibitory TGF beta 1/IFN beta cytokine pathway.
Arany I; Rady P; Tyring SK
Antiviral Res; 1994 Feb; 23(2):131-41. PubMed ID: 7511881
[TBL] [Abstract][Full Text] [Related]
15. The role of the immune system in anogenital human papillomavirus.
Frazer IH
Australas J Dermatol; 1998 Nov; 39 Suppl 1():S5-7. PubMed ID: 9842093
[TBL] [Abstract][Full Text] [Related]
16. Response to interferon treatment decreases with epidermal dedifferentiation in condylomas.
Arany I; Brysk MM; Brysk H; Tyring SK
Antiviral Res; 1996 Aug; 32(1):19-26. PubMed ID: 8863992
[TBL] [Abstract][Full Text] [Related]
17. Interferons alpha, beta and gamma therapy of anogenital human papillomavirus infections.
Rockley PF; Tyring SK
Pharmacol Ther; 1995 Feb; 65(2):265-87. PubMed ID: 7792318
[TBL] [Abstract][Full Text] [Related]
18. Circulating human papillomavirus type 16 specific T-cells are associated with HLA Class I expression on tumor cells, but not related to the amount of viral oncogene transcripts.
de Boer MA; Jordanova ES; van Poelgeest MI; van den Akker BE; van der Burg SH; Kenter GG; Fleuren GJ
Int J Cancer; 2007 Dec; 121(12):2711-5. PubMed ID: 17724722
[TBL] [Abstract][Full Text] [Related]
19. Cellular subsets and epithelial ICAM-1 and HLA-DR expression in human papillomavirus infection of the vulva.
Morelli AE; Belardi G; DiPaola G; Paredes A; Fainboim L
Acta Derm Venereol; 1994 Jan; 74(1):45-50. PubMed ID: 7908483
[TBL] [Abstract][Full Text] [Related]
20. Randomized controlled trial of an adjuvanted human papillomavirus (HPV) type 6 L2E7 vaccine: infection of external anogenital warts with multiple HPV types and failure of therapeutic vaccination.
Vandepapeliere P; Barrasso R; Meijer CJ; Walboomers JM; Wettendorff M; Stanberry LR; Lacey CJ
J Infect Dis; 2005 Dec; 192(12):2099-107. PubMed ID: 16288373
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
